27 related articles for article (PubMed ID: 27341997)
1. The Relationship Between Metformin and Serum Prostate-Specific Antigen Levels.
Jayalath VH; Ireland C; Fleshner NE; Hamilton RJ; Jenkins DJ
Prostate; 2016 Nov; 76(15):1445-53. PubMed ID: 27403913
[TBL] [Abstract][Full Text] [Related]
2. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18.
Bello D; Webber MM; Kleinman HK; Wartinger DD; Rhim JS
Carcinogenesis; 1997 Jun; 18(6):1215-23. PubMed ID: 9214605
[TBL] [Abstract][Full Text] [Related]
3. Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models.
Morale MG; Tamura RE; Rubio IGS
Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327549
[TBL] [Abstract][Full Text] [Related]
4. Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway.
Chen C; Wang H; Geng X; Zhang D; Zhu Z; Zhang G; Hou J
Cancer Cell Int; 2021 Aug; 21(1):404. PubMed ID: 34399755
[TBL] [Abstract][Full Text] [Related]
5. The Mevalonate Pathway, a Metabolic Target in Cancer Therapy.
Guerra B; Recio C; Aranda-Tavío H; Guerra-Rodríguez M; García-Castellano JM; Fernández-Pérez L
Front Oncol; 2021; 11():626971. PubMed ID: 33718197
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycosylation end products (AGEs) controls proliferation, invasion and permeability through orchestrating ARHGAP18/RhoA pathway in human umbilical vein endothelial cells.
Li X; Tao Y; Wang X; Wang T; Liu J
Glycoconj J; 2020 Apr; 37(2):209-219. PubMed ID: 32016689
[TBL] [Abstract][Full Text] [Related]
7. Disparities in prostate cancer incidence and mortality rates: Solvable or not?
Badal S; Aiken W; Morrison B; Valentine H; Bryan S; Gachii A; Ragin C
Prostate; 2020 Jan; 80(1):3-16. PubMed ID: 31702061
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of
Arroyo-Acevedo JL; Rojas-Armas JP; Herrera-Calderón O; Chávez-Asmat R; Justil-Guerrero HJ; Aguilar-Carranza C; Enciso-Roca E; Tinco-Jayo JA; Yuli-Posadas RÁ; Franco-Quino C; Chumpitaz-Cerrate V
Onco Targets Ther; 2019; 12():6555-6562. PubMed ID: 31616164
[TBL] [Abstract][Full Text] [Related]
9. Metformin alters H2A.Z dynamics and regulates androgen dependent prostate cancer progression.
Tyagi M; Cheema MS; Dryhurst D; Eskiw CH; Ausió J
Oncotarget; 2018 Dec; 9(97):37054-37068. PubMed ID: 30651935
[TBL] [Abstract][Full Text] [Related]
10. Concomitant attenuation of HMG-CoA reductase expression potentiates the cancer cell growth-inhibitory effect of statins and expands their efficacy in tumor cells with epithelial characteristics.
Ishikawa T; Hosaka YZ; Beckwitt C; Wells A; Oltvai ZN; Warita K
Oncotarget; 2018 Jun; 9(50):29304-29315. PubMed ID: 30034619
[TBL] [Abstract][Full Text] [Related]
11. Metformin: A Bridge between Diabetes and Prostate Cancer.
Zingales V; Distefano A; Raffaele M; Zanghi A; Barbagallo I; Vanella L
Front Oncol; 2017; 7():243. PubMed ID: 29075616
[TBL] [Abstract][Full Text] [Related]
12. Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells.
Babcook MA; Sramkoski RM; Fujioka H; Daneshgari F; Almasan A; Shukla S; Nanavaty RR; Gupta S
Cell Death Dis; 2014 Nov; 5(11):e1536. PubMed ID: 25412314
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of high and low-dose simvastatin on prostate epithelial cells: the role of LDL.
Murtola TJ; Syvälä H; Pennanen P; Bläuer M; Solakivi T; Ylikomi T; Tammela TL
Eur J Pharmacol; 2011 Dec; 673(1-3):96-100. PubMed ID: 22040920
[TBL] [Abstract][Full Text] [Related]
14. The importance of LDL and cholesterol metabolism for prostate epithelial cell growth.
Murtola TJ; Syvälä H; Pennanen P; Bläuer M; Solakivi T; Ylikomi T; Tammela TL
PLoS One; 2012; 7(6):e39445. PubMed ID: 22761797
[TBL] [Abstract][Full Text] [Related]
15. Colorectal and Prostate Cancer Risk in Diabetes: Metformin, an Actor behind the Scene.
Anwar MA; Kheir WA; Eid S; Fares J; Liu X; Eid AH; Eid AA
J Cancer; 2014; 5(9):736-44. PubMed ID: 25368673
[TBL] [Abstract][Full Text] [Related]
16. The effects of metformin and simvastatin on the growth of LNCaP and RWPE-1 prostate epithelial cell lines.
Pennanen P; Syvälä H; Bläuer M; Savinainen K; Ylikomi T; Tammela TLJ; Murtola TJ
Eur J Pharmacol; 2016 Oct; 788():160-167. PubMed ID: 27341997
[TBL] [Abstract][Full Text] [Related]
17. Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations.
Murtola TJ; Pennanen P; Syvälä H; Bläuer M; Ylikomi T; Tammela TL
Prostate; 2009 Jun; 69(9):1017-23. PubMed ID: 19301305
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
